| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 175.352 | 202.386 | 244.910 | 268.943 | 284.143 | 269.115 | 243.100 | 298.941 | 286.805 | 312.700 |
| Total Income - EUR | 176.025 | 202.677 | 245.215 | 269.071 | 284.157 | 269.130 | 243.107 | 298.949 | 341.703 | 351.088 |
| Total Expenses - EUR | 165.706 | 196.866 | 236.958 | 256.283 | 275.590 | 261.109 | 233.669 | 279.293 | 329.538 | 339.122 |
| Gross Profit/Loss - EUR | 10.319 | 5.810 | 8.257 | 12.788 | 8.567 | 8.021 | 9.438 | 19.656 | 12.165 | 11.966 |
| Net Profit/Loss - EUR | 8.651 | 4.854 | 5.769 | 10.099 | 5.726 | 5.330 | 7.004 | 16.648 | 9.292 | 9.595 |
| Employees | 3 | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 3 |
Check the financial reports for the company - Pharma T Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.802 | 1.778 | 2.661 | 7.481 | 6.937 | 6.897 | 6.852 | 34.161 | 55.399 | 2.105 |
| Current Assets | 50.251 | 45.477 | 68.086 | 87.172 | 85.737 | 89.343 | 92.510 | 101.517 | 99.081 | 131.637 |
| Inventories | 30.248 | 23.534 | 31.059 | 37.102 | 34.250 | 41.826 | 39.323 | 48.743 | 46.019 | 58.288 |
| Receivables | 16.303 | 8.071 | 32.081 | 43.351 | 34.572 | 35.049 | 36.375 | 37.596 | 34.880 | 27.934 |
| Cash | 3.701 | 13.872 | 4.946 | 6.718 | 16.915 | 12.468 | 16.812 | 15.178 | 18.183 | 45.415 |
| Shareholders Funds | 8.696 | 4.898 | 5.813 | 10.142 | 5.768 | 5.371 | 7.044 | 23.713 | 32.933 | 19.172 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 43.357 | 42.357 | 64.934 | 84.511 | 86.906 | 90.869 | 92.318 | 111.965 | 121.547 | 114.571 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharma T Srl